Variant report

Variant	nsv613786
Chromosome Location	chr9:22610366-22749670
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr9:22642399-22642402	GM12878	blood:	n/a	n/a
2	BRCA1	chr9:22669815-22669872	Hela-S3	cervix:	n/a	n/a
3	CEBPB	chr9:22625577-22625907	H1-hESC	embryonic stem cell:	n/a	chr9:22625725-22625736
4	CEBPB	chr9:22683693-22684086	IMR90	lung:	n/a	n/a
5	CEBPB	chr9:22683053-22683457	Hela-S3	cervix:	n/a	chr9:22683166-22683179
6	CEBPB	chr9:22642451-22642589	HepG2	liver:	n/a	chr9:22642528-22642539
7	CEBPB	chr9:22625550-22625897	A549	lung:	n/a	chr9:22625725-22625736
8	CEBPB	chr9:22709428-22709726	IMR90	lung:	n/a	n/a
9	CEBPB	chr9:22611437-22611617	HepG2	liver:	n/a	chr9:22611512-22611523
10	CEBPB	chr9:22709485-22709771	HepG2	liver:	n/a	n/a
11	CEBPB	chr9:22696362-22696521	Hela-S3	cervix:	n/a	chr9:22696461-22696470 chr9:22696459-22696472 chr9:22696461-22696470 chr9:22696461-22696470 chr9:22696459-22696472
12	CEBPB	chr9:22693164-22693367	IMR90	lung:	n/a	n/a
13	CEBPB	chr9:22683775-22683981	MCF-7	breast:	n/a	n/a
14	CEBPB	chr9:22642450-22642606	A549	lung:	n/a	chr9:22642528-22642539
15	CEBPB	chr9:22625551-22625900	HepG2	liver:	n/a	chr9:22625725-22625736
16	CEBPB	chr9:22696377-22696528	H1-hESC	embryonic stem cell:	n/a	chr9:22696461-22696470 chr9:22696459-22696472 chr9:22696461-22696470 chr9:22696461-22696470 chr9:22696459-22696472
17	CEBPB	chr9:22627879-22628176	H1-hESC	embryonic stem cell:	n/a	n/a
18	CEBPB	chr9:22611394-22611636	IMR90	lung:	n/a	chr9:22611512-22611523
19	CEBPB	chr9:22683049-22683464	IMR90	lung:	n/a	chr9:22683166-22683179
20	CEBPB	chr9:22709513-22709726	A549	lung:	n/a	n/a
21	CEBPB	chr9:22683718-22684087	Hela-S3	cervix:	n/a	n/a
22	CEBPB	chr9:22683155-22683272	A549	lung:	n/a	chr9:22683166-22683179
23	CEBPB	chr9:22660568-22660768	Hela-S3	cervix:	n/a	n/a
24	CEBPB	chr9:22682459-22682654	Hela-S3	cervix:	n/a	n/a
25	CEBPB	chr9:22625549-22625906	IMR90	lung:	n/a	chr9:22625725-22625736
26	CEBPB	chr9:22695388-22695662	IMR90	lung:	n/a	n/a
27	CEBPB	chr9:22625667-22625834	MCF-7	breast:	n/a	chr9:22625725-22625736
28	CEBPB	chr9:22696309-22696578	IMR90	lung:	n/a	chr9:22696461-22696470 chr9:22696459-22696472 chr9:22696461-22696470 chr9:22696461-22696470 chr9:22696459-22696472
29	CTCF	chr9:22718120-22718270	NHLF	lung:	n/a	n/a
30	CTCF	chr9:22718800-22718950	MCF-7	breast:	n/a	chr9:22718838-22718854 chr9:22718837-22718855
31	CTCF	chr9:22625521-22625549	Lung_OC	lung:	n/a	n/a
32	CTCF	chr9:22718780-22718930	HCPEpiC	choroid plexus:	n/a	chr9:22718838-22718854 chr9:22718837-22718855
33	CTCF	chr9:22718840-22718990	HCT-116	colon:	n/a	n/a
34	CTCF	chr9:22717308-22717449	MCF-7	breast:	n/a	n/a
35	CTCF	chr9:22718800-22718950	GM12872	blood:	n/a	chr9:22718838-22718854 chr9:22718837-22718855
36	CTCF	chr9:22699540-22699690	NHLF	lung:	n/a	n/a
37	CTCF	chr9:22717300-22717450	RPTEC	kidney:	n/a	n/a
38	CTCF	chr9:22718728-22718956	IMR90	lung:	n/a	chr9:22718838-22718854 chr9:22718837-22718855
39	CTCF	chr9:22717240-22717390	MCF-7	breast:	n/a	n/a
40	CTCF	chr9:22717341-22717424	MCF-7	breast:	n/a	n/a
41	CTCF	chr9:22719120-22719270	AG10803	skin:	n/a	n/a
42	CTCF	chr9:22717260-22717410	AoAF	blood vessel:	n/a	n/a
43	CTCF	chr9:22718280-22718430	HMF	breast:	n/a	n/a
44	CTCF	chr9:22718720-22718870	AG04450	lung:	n/a	chr9:22718838-22718854 chr9:22718837-22718855
45	CTCF	chr9:22718740-22718890	AG09319	gingival:	n/a	chr9:22718838-22718854 chr9:22718837-22718855
46	CTCF	chr9:22718740-22718890	AG10803	skin:	n/a	chr9:22718838-22718854 chr9:22718837-22718855
47	CTCF	chr9:22718780-22718930	AoAF	blood vessel:	n/a	chr9:22718838-22718854 chr9:22718837-22718855
48	CTCF	chr9:22717340-22717490	HRE	kidney:	n/a	n/a
49	CTCF	chr9:22717220-22717370	HMF	breast:	n/a	n/a
50	CTCF	chr9:22718740-22718890	AG04450	lung:	n/a	chr9:22718838-22718854 chr9:22718837-22718855

No.	Distal block	Cell Line	Cell type
1	chr15:65596519..65598485-chr9:22707844..22709364,2	MCF-7	breast:
2	chr7:2109017..2109524-chr9:22685897..22686685,2	MCF-7	breast:
3	chr15:65596803..65598452-chr9:22707864..22709364,2	K562	blood:
4	chr15:65596780..65597412-chr9:22707344..22708364,4	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DMRTA1-2	chr9:22674442-22674642	ENSG00000234840.1
2	lnc-DMRTA1-11	chr9:22716040-22716456	NONHSAT130445
3	lnc-DMRTA1-2	chr9:22646199-22646295	ENSG00000234840.1
4	lnc-DMRTA1-12	chr9:22728286-22728585	NONHSAT130446
5	lnc-DMRTA1-2	chr9:22682469-22682712	ENSG00000234840.1
6	lnc-DMRTA1-1	chr9:22674481-22674642	NONHSAT130443
7	lnc-DMRTA1-1	chr9:22683873-22684083	NONHSAT130441
8	lnc-DMRTA1-1	chr9:22682609-22682712	NONHSAT130443
9	lnc-CDKN2B-5	chr9:22651795-22652209	NONHSAT130440
10	lnc-CDKN2B-5	chr9:22636866-22636923	NONHSAT130440
11	lnc-DMRTA1-1	chr9:22687546-22688453	NONHSAT130441
12	lnc-DMRTA1-1	chr9:22646108-22646877	NONHSAT130441
13	lnc-DMRTA1-2	chr9:22687546-22687626	ENSG00000234840.1
14	lnc-DMRTA1-12	chr9:22725718-22725880	NONHSAT130446
15	lnc-DMRTA1-2	chr9:22723308-22723429	ENSG00000234840.1
16	lnc-DMRTA1-10	chr9:22672609-22672712	l_3742_chr9:22664441-22713435_adipose
17	lnc-DMRTA1-1	chr9:22723308-22723429	NONHSAT130443
18	lnc-DMRTA1-1	chr9:22674434-22674694	NONHSAT130441
19	lnc-DMRTA1-1	chr9:22682469-22683267	NONHSAT130441
20	lnc-DMRTA1-2	chr9:22682609-22682712	ENSG00000234840.1
21	lnc-DMRTA1-10	chr9:22664442-22664642	l_3742_chr9:22664441-22713435_adipose
22	lnc-DMRTA1-11	chr9:22714322-22715083	NONHSAT130445
23	lnc-DMRTA1-10	chr9:22713308-22713435	l_3742_chr9:22664441-22713435_adipose
24	lnc-DMRTA1-11	chr9:22715216-22715757	NONHSAT130445

Variant related genes	Relation type
ENSG00000236739	TF binding region
ENSG00000234840	TF binding region
ENSG00000200156	chromatin interactions

Extended variants
information (count: 5106 )
Associated
traits (count: 155 )

Variant overlapped rSNPs/rCNVs (count:5106 , 50 per page) page: 1 2 3 4 5 6 7 ... 103

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4551449	chr9:22610366-22610367	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs187958818	chr9:22610372-22610373	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs377065716	chr9:22610379-22610380	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs530300245	chr9:22610397-22610398	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs550034346	chr9:22610435-22610436	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs536352745	chr9:22610444-22610445	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs570154711	chr9:22610484-22610485	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs532435223	chr9:22610485-22610486	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs192966313	chr9:22610487-22610488	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs138574126	chr9:22610509-22610510	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs4313236	chr9:22610531-22610532	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
12	rs547658143	chr9:22610564-22610565	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs567380624	chr9:22610578-22610579	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs536471792	chr9:22610582-22610583	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs556053686	chr9:22610586-22610587	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs576216716	chr9:22610599-22610600	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs538691783	chr9:22610641-22610642	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs572867635	chr9:22610650-22610651	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs7874065	chr9:22610694-22610695	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs572061612	chr9:22610744-22610745	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs541395386	chr9:22610747-22610748	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs561604858	chr9:22610751-22610752	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs61339727	chr9:22610786-22610787	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs556438970	chr9:22610798-22610799	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs183574165	chr9:22610803-22610804	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs576568901	chr9:22610830-22610831	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs544009619	chr9:22610908-22610909	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs144067660	chr9:22610975-22610976	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs532471629	chr9:22610988-22610989	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs552247532	chr9:22611020-22611021	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs555476649	chr9:22611100-22611101	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs559359873	chr9:22611113-22611114	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs76646283	chr9:22611132-22611133	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs188013579	chr9:22611152-22611153	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs10811751	chr9:22611155-22611156	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs7019846	chr9:22611166-22611167	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs373763961	chr9:22611177-22611178	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs7019754	chr9:22611198-22611199	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs569864568	chr9:22611208-22611209	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs529902064	chr9:22611250-22611251	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs375555696	chr9:22611262-22611263	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs372466379	chr9:22611281-22611282	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs566800292	chr9:22611305-22611306	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs572098908	chr9:22611317-22611318	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs534634316	chr9:22611323-22611324	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs150302011	chr9:22611334-22611335	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs377008467	chr9:22611351-22611352	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs575086445	chr9:22611375-22611376	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs543709197	chr9:22611378-22611379	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs191365878	chr9:22611392-22611393	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:155)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic myeloid leukemia	21384125	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Cancer	22183965	CNVD
Glioblastoma multiforme	21569311	CNVD
Myelofibrosis	22110671	CNVD
Ewing''s sarcoma	22429812	CNVD
Neuroblastoma	21899760	CNVD
Glioblastoma multiforme	19435819	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Glioblastoma multiforme	22291905	CNVD
Lung cancer	21911935	CNVD
Primary central nervous system lymphoma	21088137	CNVD
head and neck squamous cell carcinoma	21798897	CNVD
Cancer	21253487	CNVD
Glioblastoma multiforme	22286061	CNVD
Intracranial ependymoma	16609018	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Glioblastoma multiforme	21922591	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Urothelial cell carcinoma	18451213	CNVD
Glioma	17123091	CNVD
Mental retardation	17124404	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Acute lymphoblastic leukemia	18768390	CNVD
Leukemia	19602459	CNVD
Acute monocytic leukemia	16498392	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Leukemia	18688285	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Acute myeloid leukemia	19651601	CNVD
Coronary Disease	20032323	CNVD
Squamous cell cancer	20885788	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21732550	CNVD
Gastric cancer	22539939	CNVD
Cancer	21183584	CNVD
T-cell lymphomas	19863542	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Metastatic melanoma	18483359	CNVD
Non-small cell lung cancer	20864512	CNVD
Cervical cancer	21062161	CNVD
Acute myeloid leukemia	16864856	CNVD
Glioblastoma	17090523	CNVD
Lung cancer	16773561	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16774939	CNVD
Bladder cancer	19088036	CNVD
Colorectal cancer	16272173	CNVD
Melanoma	16977458	CNVD
Glioblastoma multiforme	17369134	CNVD
Chagasic megaesophagus	20163722	CNVD
Melanoma	19566914	CNVD
Squamous cell cancer	19047905	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Hodgkin''s lymphoma	18179710	CNVD
Glioma	20126413	CNVD
Melanoma	17363583	CNVD
Glioblastoma multiforme	19115005	CNVD
Glioblastoma multiforme	21138945	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Cancer	20581869	CNVD
Oral cancer	22144094	CNVD
Barrett''s syndrome	19417022	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Acute myeloid leukemia	21251322	CNVD
Oral cancer	21386901	CNVD
Breast cancer	21364760	CNVD
Acute myeloid leukemia	17237825	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Glioblastoma multiforme	21525872	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:273 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:22596000-22618000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
2	chr9:22608000-22610400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
3	chr9:22608400-22610400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
4	chr9:22610000-22610600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
5	chr9:22610400-22610600	Enhancers	HUES64 Cell Line	embryonic stem cell
6	chr9:22610400-22610800	Enhancers	iPS-20b Cell Line	embryonic stem cell
7	chr9:22610400-22611000	Enhancers	ES-I3 Cell Line	embryonic stem cell
8	chr9:22610400-22612600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
9	chr9:22610600-22610800	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
10	chr9:22615200-22615800	Active TSS	Fetal Heart	heart
11	chr9:22616600-22618000	Enhancers	Psoas Muscle	Psoas
12	chr9:22616600-22618000	Enhancers	Skeletal Muscle Female	skeletal muscle
13	chr9:22617000-22618000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
14	chr9:22617200-22617800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
15	chr9:22617400-22618000	Enhancers	Skeletal Muscle Male	skeletal muscle
16	chr9:22617800-22622600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
17	chr9:22618000-22622800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
18	chr9:22622200-22623400	Enhancers	Fetal Stomach	stomach
19	chr9:22622200-22623600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr9:22622600-22624400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
21	chr9:22622800-22623400	Enhancers	Ovary	ovary
22	chr9:22622800-22623600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
23	chr9:22622800-22624000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
24	chr9:22623000-22623400	Enhancers	H1 Cell Line	embryonic stem cell
25	chr9:22623000-22623400	Enhancers	HUES6 Cell Line	embryonic stem cell
26	chr9:22623000-22623600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
27	chr9:22623000-22623800	Enhancers	HUES64 Cell Line	embryonic stem cell
28	chr9:22623000-22624000	Enhancers	iPS-18 Cell Line	embryonic stem cell
29	chr9:22623200-22623800	Enhancers	HUES48 Cell Line	embryonic stem cell
30	chr9:22623200-22623800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
31	chr9:22623600-22624000	Enhancers	iPS-15b Cell Line	embryonic stem cell
32	chr9:22623800-22629200	Weak transcription	HUES48 Cell Line	embryonic stem cell
33	chr9:22623800-22631000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
34	chr9:22628000-22628200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
35	chr9:22629200-22629600	Enhancers	iPS-20b Cell Line	embryonic stem cell
36	chr9:22629200-22631600	Enhancers	HUES48 Cell Line	embryonic stem cell
37	chr9:22629400-22632000	Enhancers	HUES64 Cell Line	embryonic stem cell
38	chr9:22629600-22630400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
39	chr9:22630200-22631600	Enhancers	iPS-18 Cell Line	embryonic stem cell
40	chr9:22630400-22631600	Enhancers	HUES6 Cell Line	embryonic stem cell
41	chr9:22630400-22631600	Enhancers	iPS-15b Cell Line	embryonic stem cell
42	chr9:22630400-22631600	Enhancers	iPS-20b Cell Line	embryonic stem cell
43	chr9:22631000-22631600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
44	chr9:22631000-22631800	Enhancers	ES-I3 Cell Line	embryonic stem cell
45	chr9:22631200-22631600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
46	chr9:22640200-22640800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
47	chr9:22643200-22644200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
48	chr9:22643200-22645800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
49	chr9:22643600-22644200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
50	chr9:22644200-22645200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links